SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-025720
Filing Date
2023-07-27
Accepted
2023-07-27 17:16:58
Documents
15
Period of Report
2023-07-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42222
2 ex3-1.htm EX-3.1 1213
3 ex99-1.htm EX-99.1 12378
4 ex3-1_001.jpg GRAPHIC 412769
  Complete submission text file 0001493152-23-025720.txt   803613

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT invo-20230726.xsd EX-101.SCH 3033
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT invo-20230726_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT invo-20230726_pre.xml EX-101.PRE 22371
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3308
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 231119441
SIC: 3841 Surgical & Medical Instruments & Apparatus